• A Turning Point in ALS Trials

  • Oct 21 2024
  • Length: 45 mins
  • Podcast

A Turning Point in ALS Trials

Listen for free

View show details

  • Summary

  • To drive a turnaround in trials for ALS and other neurological diseases, we at Modality advocate for new tools that increase understanding of the course of disease and response to treatment. Together with MGH, Everything ALS, and, more recently, Verge Genomics, Modality’s platform is building the most comprehensive audio/visual dataset of people living with ALS. In this 45-minute call, we discuss advancements in digital endpoints in clinical trials and the potential to accelerate clinical research. Our special guest is Karl Kieburtz, MD, MPH, Co-Founder and Chair of Clintrex and principal investigator for numerous multi-center trials in neurology.
    Show more Show less
Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about A Turning Point in ALS Trials

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available